Skip to main content Accessibility help
×
Home

Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong

  • Vincent C. C. Cheng (a1) (a2), Shuk-Ching Wong (a2), Jonathan H. K. Chen (a1), Cyril C. Y. Yip (a1), Vivien W. M. Chuang (a3), Owen T. Y. Tsang (a4), Siddharth Sridhar (a5), Jasper F. W. Chan (a5), Pak-Leung Ho (a5) and Kwok-Yung Yuen (a5)...

Abstract

Objective:

To describe the infection control preparedness measures undertaken for coronavirus disease (COVID-19) due to SARS-CoV-2 (previously known as 2019 novel coronavirus) in the first 42 days after announcement of a cluster of pneumonia in China, on December 31, 2019 (day 1) in Hong Kong.

Methods:

A bundled approach of active and enhanced laboratory surveillance, early airborne infection isolation, rapid molecular diagnostic testing, and contact tracing for healthcare workers (HCWs) with unprotected exposure in the hospitals was implemented. Epidemiological characteristics of confirmed cases, environmental samples, and air samples were collected and analyzed.

Results:

From day 1 to day 42, 42 of 1,275 patients (3.3%) fulfilling active (n = 29) and enhanced laboratory surveillance (n = 13) were confirmed to have the SARS-CoV-2 infection. The number of locally acquired case significantly increased from 1 of 13 confirmed cases (7.7%, day 22 to day 32) to 27 of 29 confirmed cases (93.1%, day 33 to day 42; P < .001). Among them, 28 patients (66.6%) came from 8 family clusters. Of 413 HCWs caring for these confirmed cases, 11 (2.7%) had unprotected exposure requiring quarantine for 14 days. None of these was infected, and nosocomial transmission of SARS-CoV-2 was not observed. Environmental surveillance was performed in the room of a patient with viral load of 3.3 × 106 copies/mL (pooled nasopharyngeal and throat swabs) and 5.9 × 106 copies/mL (saliva), respectively. SARS-CoV-2 was identified in 1 of 13 environmental samples (7.7%) but not in 8 air samples collected at a distance of 10 cm from the patient’s chin with or without wearing a surgical mask.

Conclusion:

Appropriate hospital infection control measures was able to prevent nosocomial transmission of SARS-CoV-2.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

Author for correspondence: Kwok-Yung Yuen, E-mail: kyyuen@hku.hk

Footnotes

Hide All
a

Authors of equal contribution.

Footnotes

References

Hide All
1.Zhu, N, Zhang, D, Wang, W, et al.A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727733.
2.Novel Coronavirus (2019-nCoV) situation report-1. World Health Organization website. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4. Published January 21, 2020. Accessed February 10, 2020.
3.Cheng, VC, Lau, SK, Woo, PC, Yuen, KY.Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007;20:660694.
4.Cheng, VC, Chan, JF, To, KK, Yuen, KY.Clinical management and infection control of SARS: lessons learned. Antiviral Res 2013;100:407419.
5.Chan, JF, Lau, SK, To, KK, Cheng, VC, Woo, PC, Yuen, KY.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 2015;28:465522.
6.Coronavirus disease 2019 (COVID-19) situation report-28. World Health Organization website. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200217-sitrep-28-covid-19.pdf?sfvrsn=a19cf2ad_2. Published February 17, 2020. Accessed February 19, 2020.
7.Wong, ATY, Chen, H, Liu, SH, et al.From SARS to avian influenza preparedness in Hong Kong. Clin Infect Dis 2017;64:S98S104.
8.Cheng, VCC, Wong, SC, To, KKW, Ho, PL, Yuen, KY.Preparedness and proactive infection control measures against the emerging novel coronavirus in China. J Hosp Infect 2020. pii: S0195-6701(20)30034-7. doi: 10.1016/j.jhin.2020.01.010.
9.Cheng, VC, Tai, JW, Lee, WM, et al.Infection control preparedness for human infection with influenza A H7N9 in Hong Kong. Infect Control Hosp Epidemiol 2015;36:8792.
10.Yip, CC, Lam, CS, Luk, HK, et al.A six-year descriptive epidemiological study of human coronavirus infections in hospitalized patients in Hong Kong. Virol Sin 2016;31:4148.
11.Chan, JF, Yip, CC, To, KK, et al.Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol 2020. pii: JCM.00310-20. doi: 10.1128/JCM.00310-20.
12.Cheng, VCC, Wong, SC, Chiu, KHY, Yip, CCY, Wong, SCY, Yuen, KY.Detection of norovirus in air samples in a non-vomiting patient: implications of testing saliva for norovirus in an immunocompromised host. J Hosp Infect 2019;103:357358.
13.Cheng, VCC, Wong, SC, Wong, SCY, et al.Measles outbreak from Hong Kong International Airport to the hospital due to secondary vaccine failure in healthcare workers. Infect Control Hosp Epidemiol 2019;40:14071415.
14.Wu, J, Xu, F, Zhou, W, et al.Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis 2004;10:210216.
15.Loeb, M, McGeer, A, Henry, B, et al.SARS among critical care nurses, Toronto. Emerg Infect Dis 2004;10:251255.
16.Cheng, VC, Tai, JW, Wong, LM, et al.Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle. J Hosp Infect 2010;74:271277.
17.Cheng, VC, To, KK, Tse, H, Hung, IF, Yuen, KY.Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev 2012;25:223263.
18.Wong, VW, Cowling, BJ, Aiello, AE.Hand hygiene and risk of influenza virus infections in the community: a systematic review and meta-analysis. Epidemiol Infect 2014;142:922932.
19.Cheng, VC, Tai, JW, Li, WS, et al.Implementation of directly observed patient hand hygiene for hospitalized patients by hand hygiene ambassadors in Hong Kong. Am J Infect Control 2016;44:621624.
20.Cheng, VCC, Wong, SC, Wong, SCY, Yuen, KY.Directly observed hand hygiene—from healthcare workers to patients. J Hosp Infect 2019;101:380382.
21.Roy, CJ, Milton, DK.Airborne transmission of communicable infection—the elusive pathway. N Engl J Med 2004;350:17101712.
22.Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. World Health Organization website. https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125. Published January 25, 2020. Accessed February 10, 2020.
23.Chan, KH, Peiris, JS, Lam, SY, Poon, LL, Yuen, KY, Seto, WH.The effects of temperature and relative humidity on the viability of the SARS coronavirus. Adv Virol 2011;2011:734690.
24.To, KKW, Tsang, OTY YC, Chan, KH, et al.Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa149.
25.Chan, JF, Yuan, S, Kok, KH, et al.A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514523.
26.Huang, C, Wang, Y, Li, X, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497506.
27.Phan, LT, Nguyen, TV, Luong, QC, et al.Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med 2020. doi: 10.1056/NEJMc2001272.
28.Ren, LL, Wang, YM, Wu, ZQ, et al.Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl) 2020. PMID: 32004165. doi: 10.1097/CM9.0000000000000722.
29.Holshue, ML, DeBolt, C, Lindquist, S, et al.First case of 2019 novel coronavirus in the United States. N Engl J Med 2020. doi: 10.1056/NEJMoa2001191.
30.Chen, N, Zhou, M, Dong, X, et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507513.

Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong

  • Vincent C. C. Cheng (a1) (a2), Shuk-Ching Wong (a2), Jonathan H. K. Chen (a1), Cyril C. Y. Yip (a1), Vivien W. M. Chuang (a3), Owen T. Y. Tsang (a4), Siddharth Sridhar (a5), Jasper F. W. Chan (a5), Pak-Leung Ho (a5) and Kwok-Yung Yuen (a5)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.